Table of Contents
Advances in Nephrology
Volume 2014, Article ID 727135, 7 pages
Review Article

Fragility Fractures in Chronic Kidney Disease: Assessment and Pharmacologic Management

1Department of Internal Medicine, Eastern Health, Albert Street, Melbourne, VIC 3156, Australia
2Department of Medicine, North West Academic Centre, University of Melbourne, St. Albans, Melbourne, VIC 3021, Australia
3Division of Internal Medicine, Western Health, Gordon Street, Melbourne, VIC 3011, Australia
4University of Melbourne, Melbourne, VIC 3010, Australia

Received 28 May 2014; Accepted 25 August 2014; Published 16 September 2014

Academic Editor: Francois Madore

Copyright © 2014 Mahesan Anpalahan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Fractures are common in all stages of chronic kidney disease (CKD), and are associated with increased morbidity and mortality. Both CKD and osteoporosis often coexist as they both are strongly age associated. However, the management of fragility fractures in CKD poses many dilemmas. These include diagnosing the aetiology of fractures and choosing appropriate treatment. This paper reviews the current evidence for the assessment and pharmacologic management of fragility fractures in CKD.